Clinical analysis of patients with systemic lupus erythematosus associated with central nervous system impairment

TANG Hui-dong,PAN Meng,REN Yi,CHEN Sheng-di
2009-01-01
Abstract:Objective To investigate the clinical characteristics of central nervous system (CNS) impairment in patients with systemic lupus erythematosus (SLE). Methods The clinical characteristics of 41 SLE patients with central nervous system impairment (38 female, 3 male) were analyzed retrospectively. Results Diffuse clinical symptom presentation was the most common manifestation (51.2%) in SLE patients with central nervous system impairment, followed by focal clinical symptom presentation (22.0%), seizure presentation (12.2%), and other clinical symptom presentation (14.6%). Central nervous system impairment occurred in 29 (71.7%) patients within 3 years after onset of SLE. Twenty-seven (84.3%) of the 32 cases performed electroencephalography had abnormal electroencephalogram (EEG). Twenty (95.2%) of 21 patients with diffused clinical symptom presentation showed abnormal EEG, and 13 (59.1%) of 22 patients with focal clinical symptom presentation showed abnormal MRI imaging. Twenty-one patients accompanying albuminuria were treated with immune inhibitor (cyclophosphamide, CTX) combined with cortical steroid, the rest of 20 patients were treated with cortical steroid only. The curative effects in the former therapy might be better than that in the later(χ2=5.91, P=0.05). Conclusions Diffuse clinical symptom presentation is a common manifestation in SLE patients associated with central nervous system impairment. EEG examination is helpful for the early diagnosis in the patients. In SLE patients associated with central nervous system impairment, cortical steroid combined with cyclophosphoamide is more efficacious than cortical steroid alone.
What problem does this paper attempt to address?